Evidence map›Paper›PMID 35814220›Full record

ArticleFrontiers in pharmacology2022

Advanced

Deborah Spiess, Moritz Winker, Alexandra Dolder Behna, Carsten Gründemann, Ana Paula Simões-Wüst

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Safety and efficacy of a feed additive consisting ofEFSA journal. European Food Safety Authority · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Deborah SpiessDepartment of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Moritz WinkerCenter for Complementary Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Alexandra Dolder BehnaDepartment of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Carsten GründemannCenter for Complementary Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ana Paula Simões-WüstDepartment of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
University of Basel · CHUniversity of Zurich · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When confronted with non-psychotic mental disorders, pregnant women often refrain from using synthetic drugs and resort to herbal medicines such as St. John's wort, California poppy, valerian, lavender, and hops. Nevertheless, these herbal medicines have not yet been officially approved in pregnancy due to lack of safety data. Using a variety of

Indexed as

Eschscholzia californicaHumulus lupulusHypericum perforatumLavandula angustifoliamental health disorderspregnancysafetyValeriana officinalis

Identifiers

PMID35814220
PMCPMC9259859
OpenAlexW4283331865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.